1887

Abstract

In determining the efficacy of new vaccine candidates for leptospirosis, the primary end point is death and an important secondary end point is sterilizing immunity. However, evaluation of this end point is often hampered by the time-consuming demands and complexity of methods such as culture isolation (CI). In this study, we evaluated the use of an imprint (or touch preparation) method (IM) in detecting the presence of leptospires in tissues of hamsters infected with serovar Copenhageni. In a dissemination study, compared to CI, the IM led to equal or improved detection of leptospires in kidney, liver, lung and blood samples collected post-infection and overall concordance was good (=0.61). Furthermore, in an evaluation of hamsters immunized with a recombinant leptospiral protein-based vaccine candidate and subsequently challenged, the agreement between the CI and IM was very good (=0.84). These findings indicate that the IM is a rapid method for the direct observation of spp. that can be readily applied to evaluating infection in experimental animals and determining sterilizing immunity when screening potential vaccine candidates.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.014050-0
2009-12-01
2019-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/58/12/1632.html?itemId=/content/journal/jmm/10.1099/jmm.0.014050-0&mimeType=html&fmt=ahah

References

  1. Adler, B. & de la Pena Moctezuma, A. ( 2009; ). Leptospira and leptospirosis. Vet Microbiol 2009 Mar 13 [Epub ahead of print]
    [Google Scholar]
  2. Athanazio, D. A., Silva, E. F., Santos, C. S., Rocha, G. M., Vannier-Santos, M. A., McBride, A. J., Ko, A. I. & Reis, M. G. ( 2008; ). Rattus norvegicus as a model for persistent renal colonization by pathogenic Leptospira interrogans. Acta Trop 105, 176–180.[CrossRef]
    [Google Scholar]
  3. Bahamdan, K. A., Khan, A. R., Tallab, T. M. & Mourad, M. M. ( 1996; ). Value of touch preparations (imprints) for diagnosis of cutaneous leishmaniasis. Int J Dermatol 35, 558–560.[CrossRef]
    [Google Scholar]
  4. Berger, R. S., Perez-Figaredo, R. A. & Spielvogel, R. L. ( 1987; ). Leishmaniasis: the touch preparation as a rapid means of diagnosis. J Am Acad Dermatol 16, 1096–1105.[CrossRef]
    [Google Scholar]
  5. Bharti, A. R., Nally, J. E., Ricaldi, J. N., Matthias, M. A., Diaz, M. M., Lovett, M. A., Levett, P. N., Gilman, R. H., Willig, M. R. & other authors ( 2003; ). Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3, 757–771.[CrossRef]
    [Google Scholar]
  6. Cerqueira, G. M., McBride, A. J., Picardeau, M., Ribeiro, S. G., Moreira, A. N., Morel, V., Reis, M. G., Ko, A. I. & Dellagostin, O. A. ( 2009; ). Distribution of the leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp. and application of ligB to typing leptospiral isolates. J Med Microbiol 58, 1173–1181.[CrossRef]
    [Google Scholar]
  7. Ellinghausen, H. C., Jr & McCullough, W. G. ( 1965; ). Nutrition of Leptospira pomona and growth of 13 other serotypes: fractionation of oleic albumin complex and a medium of bovine albumin and polysorbate 80. Am J Vet Res 26, 45–51.
    [Google Scholar]
  8. Faine, S. B., Adler, B., Bolin, C. & Perolat, P. ( 1999; ). Leptospira and Leptospirosis, 2nd edn. Melbourne, Australia: MediSci.
  9. Faisal, S. M., Yan, W., Chen, C. S., Palaniappan, R. U., McDonough, S. P. & Chang, Y. F. ( 2008; ). Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Vaccine 26, 277–287.[CrossRef]
    [Google Scholar]
  10. Faisal, S. M., Yan, W., McDonough, S. P. & Chang, Y. F. ( 2009; ). Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. Vaccine 27, 378–387.[CrossRef]
    [Google Scholar]
  11. Gouveia, E. L., Metcalfe, J., de Carvalho, A. L. F., Aires, T. S., Villasboas-Bisneto, J. C., Queirroz, A., Santos, A. C., Salgado, K., Reis, M. G. & Ko, A. I. ( 2008; ). Leptospirosis-associated severe pulmonary hemorrhage syndrome, Salvador, Brazil. Emerg Infect Dis 14, 505–508.[CrossRef]
    [Google Scholar]
  12. Haake, D. A., Mazel, M. K., McCoy, A. M., Milward, F., Chao, G., Matsunaga, J. & Wagar, E. A. ( 1999; ). Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun 67, 6572–6582.
    [Google Scholar]
  13. Jan, I. S., Chung, P. F., Wang, J. Y., Weng, M. H., Hung, C. C. & Lee, L. N. ( 2008; ). Cytological diagnosis of Penicillium marneffei infection. J Formos Med Assoc 107, 443–447.[CrossRef]
    [Google Scholar]
  14. Johnson, R. C. & Harris, V. G. ( 1967; ). Differentiation of pathogenic and saprophytic leptospires. I. Growth at low temperatures. J Bacteriol 94, 27–31.
    [Google Scholar]
  15. Kar, K. ( 1995; ). Serodiagnosis of leishmaniasis. Crit Rev Microbiol 21, 123–152.[CrossRef]
    [Google Scholar]
  16. Ko, A. I., Galvao Reis, M., Ribeiro Dourado, C. M., Johnson, W. D., Jr & Riley, L. W. ( 1999; ). Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 354, 820–825.[CrossRef]
    [Google Scholar]
  17. Koizumi, N. & Watanabe, H. ( 2004; ). Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine 22, 1545–1552.[CrossRef]
    [Google Scholar]
  18. Koizumi, N. & Watanabe, H. ( 2005; ). Leptospirosis vaccines: past, present, and future. J Postgrad Med 51, 210–214.
    [Google Scholar]
  19. Landis, J. R. & Koch, G. G. ( 1977; ). The measurement of observer agreement for categorical data. Biometrics 33, 159–174.[CrossRef]
    [Google Scholar]
  20. Levett, P. N. ( 2001; ). Leptospirosis. Clin Microbiol Rev 14, 296–326.[CrossRef]
    [Google Scholar]
  21. Marotto, P. C., Nascimento, C. M., Eluf-Neto, J., Marotto, M. S., Andrade, L., Sztajnbok, J. & Seguro, A. C. ( 1999; ). Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 29, 1561–1563.[CrossRef]
    [Google Scholar]
  22. Matsunaga, J., Barocchi, M. A., Croda, J., Young, T. A., Sanchez, Y., Siqueira, I., Bolin, C. A., Reis, M. G., Riley, L. W. & other authors ( 2003; ). Pathogenic Leptospira species express surface–exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol 49, 929–945.[CrossRef]
    [Google Scholar]
  23. McBride, A. J., Athanazio, D. A., Reis, M. G. & Ko, A. I. ( 2005; ). Leptospirosis. Curr Opin Infect Dis 18, 376–386.[CrossRef]
    [Google Scholar]
  24. McBride, A. J., Cerqueira, G. M., Suchard, M. A., Moreira, A. N., Zuerner, R. L., Reis, M. G., Haake, D. A., Ko, A. I. & Dellagostin, O. A. ( 2009; ). Genetic diversity of the leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp. Infect Genet Evol 9, 196–205.[CrossRef]
    [Google Scholar]
  25. Nascimento, A. L., Ko, A. I., Martins, E. A., Monteiro-Vitorello, C. B., Ho, P. L., Haake, D. A., Verjovski-Almeida, S., Hartskeerl, R. A., Marques, M. V. & other authors ( 2004; ). Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J Bacteriol 186, 2164–2172.[CrossRef]
    [Google Scholar]
  26. Olsen, I. & Stenderup, A. ( 1990; ). Clinical-mycologic diagnosis of oral yeast infections. Acta Odontol Scand 48, 11–18.[CrossRef]
    [Google Scholar]
  27. Palaniappan, R. U., Chang, Y. F., Chang, C. F., Pan, M. J., Yang, C. W., Harpending, P., McDonough, S. P., Dubovi, E., Divers, T. & other authors ( 2005; ). Evaluation of Lig-based conventional and real time PCR for the detection of pathogenic leptospires. Mol Cell Probes 19, 111–117.
    [Google Scholar]
  28. Palaniappan, R. U., McDonough, S. P., Divers, T. J., Chen, C. S., Pan, M. J., Matsumoto, M. & Chang, Y. F. ( 2006; ). Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun 74, 1745–1750.[CrossRef]
    [Google Scholar]
  29. Park, S. K., Lee, S. H., Rhee, Y. K., Kang, S. K., Kim, K. J., Kim, M. C., Kim, K. W. & Chang, W. H. ( 1989; ). Leptospirosis in Chonbuk Province of Korea in 1987: a study of 93 patients. Am J Trop Med Hyg 41, 345–351.
    [Google Scholar]
  30. Roscoe, M. ( 2005; ). Leishmaniasis: early diagnosis is key. JAAPA 18, 47–50, 53–44.
    [Google Scholar]
  31. Seder, R. A. & Mascola, J. R. ( 2003; ). Basic immunology of vaccine development. In The Vaccine Book, pp. 51–72. Edited by B. R. Bloom & P.-H. Lambert. San Diego: Academic Press.
  32. Silva, E. F., Medeiros, M. A., McBride, A. J., Matsunaga, J., Esteves, G. S., Ramos, J. G., Santos, C. S., Croda, J., Homma, A. & other authors ( 2007; ). The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 25, 6277–6286.[CrossRef]
    [Google Scholar]
  33. Silva, E. F., Santos, C. S., Athanazio, D. A., Seyffert, N., Seixas, F. K., Cerqueira, G. M., Fagundes, M. Q., Brod, C. S., Reis, M. G. & other authors ( 2008; ). Characterization of virulence of Leptospira isolates in a hamster model. Vaccine 26, 3892–3896.[CrossRef]
    [Google Scholar]
  34. Silverman, J. F. & Gay, R. M. ( 1995; ). Fine-needle aspiration and surgical pathology of infectious lesions. Morphologic features and the role of the clinical microbiology laboratory for rapid diagnosis. Clin Lab Med 15, 251–278.
    [Google Scholar]
  35. Sonrier, C., Branger, C., Michel, V., Ruvoen-Clouet, N., Ganiere, J. P. & Andre-Fontaine, G. ( 2000; ). Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine 19, 86–94.[CrossRef]
    [Google Scholar]
  36. Teixeira, A. C., Paes, M. G., Guerra Jde, O., Prata, A. & Silva-Vergara, M. L. ( 2008; ). Failure of both azithromycin and antimony to treat cutaneous leishmaniasis in Manaus, AM, Brazil. Rev Inst Med Trop Sao Paulo 50, 157–160.
    [Google Scholar]
  37. Volpini, A. C., Marques, M. J., Lopes dos Santos, S., Machado-Coelho, G. L., Mayrink, W. & Romanha, A. J. ( 2006; ). Leishmania identification by PCR of Giemsa-stained lesion imprint slides stored for up to 36 years. Clin Microbiol Infect 12, 815–818.[CrossRef]
    [Google Scholar]
  38. WHO & ILS ( 2003; ). Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. Malta: World Health Organization.
  39. Yan, W., Faisal, S. M., McDonough, S. P., Divers, T. J., Barr, S. C., Chang, C. F., Pan, M. J. & Chang, Y. F. ( 2009; ). Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model. Microbes Infect 11, 230–237.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.014050-0
Loading
/content/journal/jmm/10.1099/jmm.0.014050-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error